Supporting Evidence

1535 bookmarks
Newest
NEW INTERVIEW - "THE MODIFIED RNA IN THESE LIPIDS ARE NOT 100% CLEAN" - Prof. Ulrike Kämmerer meticulously covers some concerning "features" of both the mRNA lipid nanoparticles and the spike protein. LEADING RESEARCHERS ARE FINDING THE SAME. THREAD 🧵
NEW INTERVIEW - "THE MODIFIED RNA IN THESE LIPIDS ARE NOT 100% CLEAN" - Prof. Ulrike Kämmerer meticulously covers some concerning "features" of both the mRNA lipid nanoparticles and the spike protein. LEADING RESEARCHERS ARE FINDING THE SAME. THREAD 🧵
Start - DNA CONTAMINATION… — Humanspective (@Humanspective)
·x.com·
NEW INTERVIEW - "THE MODIFIED RNA IN THESE LIPIDS ARE NOT 100% CLEAN" - Prof. Ulrike Kämmerer meticulously covers some concerning "features" of both the mRNA lipid nanoparticles and the spike protein. LEADING RESEARCHERS ARE FINDING THE SAME. THREAD 🧵
Pfizer reportedly withheld presence of cancer-linked DNA in COVID jabs from FDA, Health Canada - LifeSite
Pfizer reportedly withheld presence of cancer-linked DNA in COVID jabs from FDA, Health Canada - LifeSite
According to information released by the Epoch Times, Pfizer purposefully failed to advise drug regulators, including Health Canada, the U.S. FDA and the European Medicines Agency, that the cancer-linked SV40 DNA enhancer was present in their experimental COVID shot.
·lifesitenews.com·
Pfizer reportedly withheld presence of cancer-linked DNA in COVID jabs from FDA, Health Canada - LifeSite
A haunting clip. The list of peer-reviewed studies on vaccine harms which starts about half way through is particularly sobering, as is this towards the end:
A haunting clip. The list of peer-reviewed studies on vaccine harms which starts about half way through is particularly sobering, as is this towards the end:
“Children 5 - 11 year old one year after taking Pfizer mRNA vaccines showing relevant risk of developing cancer during… — Molly Kingsley (@lensiseethrough)
·x.com·
A haunting clip. The list of peer-reviewed studies on vaccine harms which starts about half way through is particularly sobering, as is this towards the end:
Comparative Safety of BNT162b2 and mRNA-1273 Vaccines in a Nationwide Cohort of US Veterans - PubMed
Comparative Safety of BNT162b2 and mRNA-1273 Vaccines in a Nationwide Cohort of US Veterans - PubMed
The findings of this cohort study suggest that there were few differences in risk of adverse events within 14 days of the first dose of either the BNT162b2 or the mRNA-1273 vaccine and small-magnitude differences within 42 days of the first dose. The 38-week risks of adverse events were low in both …
·pubmed.ncbi.nlm.nih.gov·
Comparative Safety of BNT162b2 and mRNA-1273 Vaccines in a Nationwide Cohort of US Veterans - PubMed